Circulating tumour DNA in patients with melanoma receiving targeted therapy

被引：0
|
作者：
Forschner, Andrea [1 ]
机构：
[1] Univ Hosp Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 03期
关键词：
BRAF;
D O I：
10.1016/S1470-2045(20)30758-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：291 / 293
页数：3
相关论文
共 50 条
  • [21] Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Kiely, Belinda E.
    Vasista, Anuradha
    ONCOLOGIST, 2024, 29 (11): : 922 - 930
  • [22] Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
    James Sun
    Dennis A. Kirichenko
    Joyce L. Chung
    Michael J. Carr
    Zeynep Eroglu
    Nikhil I. Khushalani
    Joseph Markowitz
    Jane L. Messina
    Vernon K. Sondak
    Jonathan S. Zager
    Sephalie Y. Patel
    World Journal of Surgery, 2020, 44 : 1283 - 1293
  • [23] Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Vasista, Anuradha
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [24] Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy
    Smith-Uffen, M.
    Park, J.
    Parsonson, A.
    Vasista, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S1611 - S1611
  • [25] Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
    Sun, James
    Kirichenko, Dennis A.
    Chung, Joyce L.
    Carr, Michael J.
    Eroglu, Zeynep
    Khushalani, Nikhil I.
    Markowitz, Joseph
    Messina, Jane L.
    Sondak, Vernon K.
    Zager, Jonathan S.
    Patel, Sephalie Y.
    WORLD JOURNAL OF SURGERY, 2020, 44 (04) : 1283 - 1293
  • [26] Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer
    Allin, D. M.
    Shaikh, R.
    Carter, P.
    Thway, K.
    Sharabiani, M. T. A.
    Gonzales-de-Castro, D.
    O'Leary, B.
    Garcia-Murillas, I.
    Bhide, S.
    Hubank, M.
    Harrington, K.
    Kim, D.
    Newbold, K.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : 165 - 175
  • [27] Circulating tumour DNA mutations correlate with relapse in a phase II trial of bortezomibprimary refractory multiple myeloma patients receiving salvage therapy
    Mithraprabhu, Sridurga
    Reynolds, John
    Kalff, Anna
    Bergin, Krystal
    Turner, Rose
    Quach, Hang
    Horvath, Noemia
    Kerridge, Ian
    Yuen, Flora
    Choi, Kawa
    Ramachandran, Malarmathy
    George, Ashley
    Khong, Tiffany
    Durie, Brian
    Spencer, Andrew
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Analysis of circulating tumour DNA could guide therapy
    Clemens Thoma
    Nature Reviews Urology, 2014, 11 (12) : 659 - 659
  • [29] Monitoring metastatic melanoma treatment resistance using circulating tumour DNA
    Murphy, S.
    Wan, J.
    Gale, D.
    Morris, J.
    Mouliere, F.
    Bignell, G.
    Alifrangis, C.
    Parkinson, C.
    Durrani, A.
    McDermott, U.
    Massie, C.
    Corrie, P.
    Rosenfeld, N.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S196 - S196
  • [30] Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
    Duffy, Michael J.
    Crown, John
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
12345